Non Small Cell Lung Cancer Keytruda Drug

User reviews for keytruda to treat non small cell lung cancer page 2 the following information is not intended to endorse any particular medication.

Non small cell lung cancer keytruda drug.

User reviews for keytruda to treat non small cell lung cancer. Keytruda is a prescription medicine used to treat a kind of lung cancer called non small cell lung cancer nsclc. Food and drug administration fda initially approved keytruda in october 2015 as a second line treatment or one used after tumor progression has continued under traditional treatments for metastatic non small cell lung cancer nsclc with high pd l1 expression determined by an fda approved diagnostic test pd l1 ihc 22c3. Merck co s keytruda may be the star in non small cell lung cancer but a combo of it and chemo just failed to significantly outdo chemo alone at prolonging patients lives in small cell.

While these reviews might be helpful they are not a substitute for the expertise knowledge and judgement of healthcare practitioners. About non small cell lung cancer. As a first treatment keytruda chemotherapy has been proven to help patients live longer compared to chemotherapy alone a clinical trial compared patients with advanced nonsquamous non small cell lung cancer who received keytruda in combination with chemotherapy with those who received chemotherapy alone. Keytruda may be used with the chemotherapy medicines pemetrexed and a platinum as your first treatment when your lung cancer has spread advanced nsclc and is a type called nonsquamous and your tumor does not have an abnormal egfr or alk gene.

The following information is not intended to endorse any particular medication. Non small cell lung cancer is cancer of the lung which is not small cell carcinoma. All patients in the trial had no previous drug treatment and did not have an.